These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
769 related articles for article (PubMed ID: 32975456)
1. Preparation, evaluation, and Pan X; Liu S; Ju L; Xi J; He R; Zhao Y; Zhuang R; Huang J Drug Dev Ind Pharm; 2020 Nov; 46(11):1889-1897. PubMed ID: 32975456 [TBL] [Abstract][Full Text] [Related]
2. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response. Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN Drug Dev Ind Pharm; 2017 Dec; 43(12):1952-1962. PubMed ID: 28724314 [TBL] [Abstract][Full Text] [Related]
3. Glycyrrhetinic Acid-Mediated Polymeric Drug Delivery Targeting the Acidic Microenvironment of Hepatocellular Carcinoma. Zhang J; Zhang M; Ji J; Fang X; Pan X; Wang Y; Wu C; Chen M Pharm Res; 2015 Oct; 32(10):3376-90. PubMed ID: 26148773 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the liver targeting and anti‑liver cancer activity of artesunate‑loaded and glycyrrhetinic acid‑coated nanoparticles. Pan XW; Huang JS; Liu SR; Shao YD; Xi JJ; He RY; Shi TT; Zhuang RX; Bao JF Exp Ther Med; 2023 Nov; 26(5):516. PubMed ID: 37854499 [TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer. Vangara KK; Liu JL; Palakurthi S Anticancer Res; 2013 Jun; 33(6):2425-34. PubMed ID: 23749891 [TBL] [Abstract][Full Text] [Related]
6. Multifunctional nanoplatform based on star-shaped copolymer for liver cancer targeting therapy. Gong X; Zheng Y; He G; Chen K; Zeng X; Chen Z Drug Deliv; 2019 Dec; 26(1):595-603. PubMed ID: 31195837 [TBL] [Abstract][Full Text] [Related]
7. PLGA-PEG-RA-based polymeric micelles for tumor targeted delivery of irinotecan. Emami J; Maghzi P; Hasanzadeh F; Sadeghi H; Mirian M; Rostami M Pharm Dev Technol; 2018 Jan; 23(1):41-54. PubMed ID: 28608760 [TBL] [Abstract][Full Text] [Related]
8. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor. Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin. Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659 [TBL] [Abstract][Full Text] [Related]
10. Glycyrrhetinic acid-decorated and reduction-sensitive micelles to enhance the bioavailability and anti-hepatocellular carcinoma efficacy of tanshinone IIA. Chen F; Zhang J; He Y; Fang X; Wang Y; Chen M Biomater Sci; 2016 Jan; 4(1):167-82. PubMed ID: 26484363 [TBL] [Abstract][Full Text] [Related]
11. Physical PEGylation Enhances The Cytotoxicity Of 5-Fluorouracil-Loaded PLGA And PCL Nanoparticles. Ashour AE; Badran M; Kumar A; Hussain T; Alsarra IA; Yassin AEB Int J Nanomedicine; 2019; 14():9259-9273. PubMed ID: 31819428 [TBL] [Abstract][Full Text] [Related]
12. Preparation, in vitro and in vivo evaluation of mPEG-PLGA nanoparticles co-loaded with syringopicroside and hydroxytyrosol. Guan Q; Sun S; Li X; Lv S; Xu T; Sun J; Feng W; Zhang L; Li Y J Mater Sci Mater Med; 2016 Feb; 27(2):24. PubMed ID: 26704541 [TBL] [Abstract][Full Text] [Related]
13. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound. Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431 [TBL] [Abstract][Full Text] [Related]
14. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer. Chen J; Li S; Shen Q; He H; Zhang Y Drug Dev Ind Pharm; 2011 Nov; 37(11):1339-46. PubMed ID: 21524153 [TBL] [Abstract][Full Text] [Related]
15. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced. Song X; Wang J; Xu Y; Shao H; Gu J Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022 [TBL] [Abstract][Full Text] [Related]
16. pH-Responsive and liver-targeting drug delivery system for combination delivery of artesunate with arsenic trioxide prodrug against hepatocellular carcinoma. Pan X; Huang J; Liu S; Shao Y; Xi J; He R; Shi T; Zhuang R; Yu W Drug Dev Ind Pharm; 2023 Aug; 49(8):485-496. PubMed ID: 37470495 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and Characterization of PLGA-PEG Thymoquinone Nanoparticles and Its Cytotoxicity Effects in Tamoxifen-Resistant Breast Cancer Cells. Ahmad R; Kaus NHM; Hamid S Adv Exp Med Biol; 2020; 1292():65-82. PubMed ID: 30560443 [TBL] [Abstract][Full Text] [Related]